In This Issue/Research Watch/News-in-Brief/News from the IASLC Tobacco Control Committee
No Target Left Behind: Improving Therapeutic Options for ERBB2 -Mutant Non–Small Cell Lung Cancer
Is Weight Loss a Loss of Chance in Patients Receiving Chemoradiotherapy?
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non–Small Cell Lung Cancer
Economic Analysis of First-Line Treatment with Erlotinib in an EGFR -Mutated Population with Advanced NSCLC
The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial
CT Features of Epidermal Growth Factor Receptor–Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma
Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer
A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis
The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs
Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC
Variations in Receipt of Curative-Intent Surgery for Early-Stage Non–Small Cell Lung Cancer (NSCLC) by State
Phase II Study of a Non-Platinum–Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma
Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study
Pulse Afatinib for ERBB2 Exon 20 Insertion–Mutated Lung Adenocarcinomas
Reliability Assurance of Detection of EML4-ALK Rearrangement in Non–Small Cell Lung Cancer: The Results of Proficiency Testing in China
Pulmonary Hydatid Cyst Mimicking a Lung Cancer
Erratum
Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib
False-Positive Axillary Lymph Nodes Due to Silicone Adenitis on 18F-FDG PET/CT in an Oncological Setting
Dealing with Lung Cancer TNM Classification
EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-EGFR and Anti-MET Therapies